nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—HTR2C—schizophrenia	0.189	0.237	CbGaD
Fluoxetine—SLC6A4—schizophrenia	0.157	0.196	CbGaD
Fluoxetine—CYP1A2—schizophrenia	0.143	0.179	CbGaD
Fluoxetine—HTR2A—schizophrenia	0.121	0.151	CbGaD
Fluoxetine—CYP2D6—schizophrenia	0.11	0.138	CbGaD
Fluoxetine—ABCB1—schizophrenia	0.0788	0.0986	CbGaD
Fluoxetine—SLC6A2—locus ceruleus—schizophrenia	0.00665	0.0784	CbGeAlD
Fluoxetine—HTR2A—locus ceruleus—schizophrenia	0.004	0.0471	CbGeAlD
Fluoxetine—HTR2C—telencephalic ventricle—schizophrenia	0.00378	0.0445	CbGeAlD
Fluoxetine—SLC6A2—autonomic nervous system—schizophrenia	0.00353	0.0417	CbGeAlD
Fluoxetine—HTR2A—cerebellar cortex—schizophrenia	0.00326	0.0384	CbGeAlD
Fluoxetine—CYP2C19—urine—schizophrenia	0.00271	0.032	CbGeAlD
Fluoxetine—HTR2A—pons—schizophrenia	0.0023	0.0272	CbGeAlD
Fluoxetine—CYP1A2—urine—schizophrenia	0.00221	0.0261	CbGeAlD
Fluoxetine—HTR2A—autonomic nervous system—schizophrenia	0.00212	0.025	CbGeAlD
Fluoxetine—CYP2C9—urine—schizophrenia	0.0021	0.0248	CbGeAlD
Fluoxetine—HTR2A—telencephalic ventricle—schizophrenia	0.0019	0.0223	CbGeAlD
Fluoxetine—HTR2A—urine—schizophrenia	0.00173	0.0204	CbGeAlD
Fluoxetine—SLC6A4—blood plasma—schizophrenia	0.00171	0.0201	CbGeAlD
Fluoxetine—HTR2A—pineal body—schizophrenia	0.00164	0.0194	CbGeAlD
Fluoxetine—CYP3A4—urine—schizophrenia	0.0016	0.0189	CbGeAlD
Fluoxetine—CYP2D6—urine—schizophrenia	0.00158	0.0186	CbGeAlD
Fluoxetine—CYP2C19—blood plasma—schizophrenia	0.00141	0.0167	CbGeAlD
Fluoxetine—CYP1A2—blood plasma—schizophrenia	0.00116	0.0136	CbGeAlD
Fluoxetine—CYP3A5—blood plasma—schizophrenia	0.00111	0.0131	CbGeAlD
Fluoxetine—CYP2B6—blood plasma—schizophrenia	0.00111	0.0131	CbGeAlD
Fluoxetine—CYP2C9—blood plasma—schizophrenia	0.0011	0.0129	CbGeAlD
Fluoxetine—HTR2C—forebrain—schizophrenia	0.000987	0.0116	CbGeAlD
Fluoxetine—SLC6A4—forebrain—schizophrenia	0.000936	0.011	CbGeAlD
Fluoxetine—Orphenadrine—GRIN2D—schizophrenia	0.000913	0.137	CrCbGaD
Fluoxetine—HTR2C—telencephalon—schizophrenia	0.000907	0.0107	CbGeAlD
Fluoxetine—HTR2A—blood plasma—schizophrenia	0.000904	0.0107	CbGeAlD
Fluoxetine—Duloxetine—HTR6—schizophrenia	0.000874	0.131	CrCbGaD
Fluoxetine—SLC6A4—telencephalon—schizophrenia	0.00086	0.0101	CbGeAlD
Fluoxetine—SIGMAR1—telencephalon—schizophrenia	0.000854	0.0101	CbGeAlD
Fluoxetine—CYP3A4—blood plasma—schizophrenia	0.000837	0.00986	CbGeAlD
Fluoxetine—SLC6A2—forebrain—schizophrenia	0.000824	0.00971	CbGeAlD
Fluoxetine—CYP2D6—blood plasma—schizophrenia	0.000823	0.0097	CbGeAlD
Fluoxetine—SLC6A2—telencephalon—schizophrenia	0.000757	0.00893	CbGeAlD
Fluoxetine—ORM1—blood—schizophrenia	0.000734	0.00865	CbGeAlD
Fluoxetine—HTR2C—midbrain—schizophrenia	0.000652	0.00768	CbGeAlD
Fluoxetine—ORM1—endocrine gland—schizophrenia	0.000637	0.00751	CbGeAlD
Fluoxetine—SLC6A2—gonad—schizophrenia	0.000632	0.00745	CbGeAlD
Fluoxetine—SLC6A4—blood—schizophrenia	0.000626	0.00737	CbGeAlD
Fluoxetine—SIGMAR1—blood—schizophrenia	0.000621	0.00732	CbGeAlD
Fluoxetine—SLC6A4—midbrain—schizophrenia	0.000618	0.00728	CbGeAlD
Fluoxetine—Orphenadrine—GRIN1—schizophrenia	0.000617	0.0924	CrCbGaD
Fluoxetine—SIGMAR1—midbrain—schizophrenia	0.000614	0.00723	CbGeAlD
Fluoxetine—ORM1—nervous system—schizophrenia	0.000596	0.00703	CbGeAlD
Fluoxetine—ABCB1—blood plasma—schizophrenia	0.000592	0.00698	CbGeAlD
Fluoxetine—ORM1—central nervous system—schizophrenia	0.000574	0.00676	CbGeAlD
Fluoxetine—SLC6A4—endocrine gland—schizophrenia	0.000543	0.0064	CbGeAlD
Fluoxetine—HTR2C—nervous system—schizophrenia	0.000536	0.00631	CbGeAlD
Fluoxetine—CYP2C19—blood—schizophrenia	0.000518	0.00611	CbGeAlD
Fluoxetine—HTR2C—central nervous system—schizophrenia	0.000516	0.00608	CbGeAlD
Fluoxetine—SLC6A4—nervous system—schizophrenia	0.000508	0.00599	CbGeAlD
Fluoxetine—HTR2A—forebrain—schizophrenia	0.000495	0.00584	CbGeAlD
Fluoxetine—SLC6A4—central nervous system—schizophrenia	0.000489	0.00576	CbGeAlD
Fluoxetine—SLC6A2—endocrine gland—schizophrenia	0.000478	0.00563	CbGeAlD
Fluoxetine—SIGMAR1—cerebellum—schizophrenia	0.000475	0.00559	CbGeAlD
Fluoxetine—CYP2B6—gonad—schizophrenia	0.000466	0.00549	CbGeAlD
Fluoxetine—Atomoxetine—HTR6—schizophrenia	0.000458	0.0686	CrCbGaD
Fluoxetine—HTR2A—telencephalon—schizophrenia	0.000455	0.00537	CbGeAlD
Fluoxetine—CYP2D6—forebrain—schizophrenia	0.000451	0.00532	CbGeAlD
Fluoxetine—CYP2C19—endocrine gland—schizophrenia	0.00045	0.0053	CbGeAlD
Fluoxetine—Duloxetine—SLC6A3—schizophrenia	0.000448	0.0671	CrCbGaD
Fluoxetine—SLC6A2—nervous system—schizophrenia	0.000447	0.00527	CbGeAlD
Fluoxetine—SLC6A2—central nervous system—schizophrenia	0.00043	0.00507	CbGeAlD
Fluoxetine—CYP1A2—blood—schizophrenia	0.000423	0.00499	CbGeAlD
Fluoxetine—CYP2D6—telencephalon—schizophrenia	0.000415	0.00489	CbGeAlD
Fluoxetine—HTR2C—brain—schizophrenia	0.000409	0.00483	CbGeAlD
Fluoxetine—CYP3A5—blood—schizophrenia	0.000408	0.00481	CbGeAlD
Fluoxetine—CYP2B6—blood—schizophrenia	0.000406	0.00478	CbGeAlD
Fluoxetine—Duloxetine—HTR2C—schizophrenia	0.000404	0.0605	CrCbGaD
Fluoxetine—CYP2C9—blood—schizophrenia	0.000402	0.00474	CbGeAlD
Fluoxetine—ALB—brain—schizophrenia	0.000399	0.00471	CbGeAlD
Fluoxetine—Cinacalcet—CYP1A2—schizophrenia	0.000389	0.0583	CrCbGaD
Fluoxetine—SLC6A4—brain—schizophrenia	0.000388	0.00458	CbGeAlD
Fluoxetine—SIGMAR1—brain—schizophrenia	0.000386	0.00454	CbGeAlD
Fluoxetine—HTR2A—gonad—schizophrenia	0.00038	0.00448	CbGeAlD
Fluoxetine—CYP1A2—endocrine gland—schizophrenia	0.000367	0.00433	CbGeAlD
Fluoxetine—CYP3A5—endocrine gland—schizophrenia	0.000354	0.00418	CbGeAlD
Fluoxetine—CYP2B6—endocrine gland—schizophrenia	0.000352	0.00415	CbGeAlD
Fluoxetine—CYP2C9—endocrine gland—schizophrenia	0.000349	0.00411	CbGeAlD
Fluoxetine—SLC6A2—brain—schizophrenia	0.000342	0.00403	CbGeAlD
Fluoxetine—Duloxetine—SLC6A4—schizophrenia	0.000335	0.0501	CrCbGaD
Fluoxetine—HTR2A—blood—schizophrenia	0.000331	0.0039	CbGeAlD
Fluoxetine—CYP2B6—nervous system—schizophrenia	0.000329	0.00388	CbGeAlD
Fluoxetine—HTR2A—midbrain—schizophrenia	0.000327	0.00385	CbGeAlD
Fluoxetine—ABCB1—forebrain—schizophrenia	0.000324	0.00382	CbGeAlD
Fluoxetine—CYP2B6—central nervous system—schizophrenia	0.000317	0.00374	CbGeAlD
Fluoxetine—CYP3A4—blood—schizophrenia	0.000306	0.00361	CbGeAlD
Fluoxetine—Duloxetine—CYP1A2—schizophrenia	0.000305	0.0457	CrCbGaD
Fluoxetine—CYP2D6—blood—schizophrenia	0.000302	0.00355	CbGeAlD
Fluoxetine—Cinacalcet—CYP2D6—schizophrenia	0.0003	0.045	CrCbGaD
Fluoxetine—ABCB1—telencephalon—schizophrenia	0.000298	0.00352	CbGeAlD
Fluoxetine—HTR2A—endocrine gland—schizophrenia	0.000287	0.00338	CbGeAlD
Fluoxetine—HTR2A—nervous system—schizophrenia	0.000269	0.00317	CbGeAlD
Fluoxetine—CYP3A4—endocrine gland—schizophrenia	0.000266	0.00313	CbGeAlD
Fluoxetine—CYP2D6—endocrine gland—schizophrenia	0.000262	0.00308	CbGeAlD
Fluoxetine—Atomoxetine—HTR1B—schizophrenia	0.00026	0.0389	CrCbGaD
Fluoxetine—HTR2A—central nervous system—schizophrenia	0.000259	0.00305	CbGeAlD
Fluoxetine—Duloxetine—HTR2A—schizophrenia	0.000257	0.0385	CrCbGaD
Fluoxetine—HTR2A—cerebellum—schizophrenia	0.000253	0.00298	CbGeAlD
Fluoxetine—CYP2B6—brain—schizophrenia	0.000252	0.00297	CbGeAlD
Fluoxetine—ABCB1—gonad—schizophrenia	0.000249	0.00293	CbGeAlD
Fluoxetine—CYP3A4—nervous system—schizophrenia	0.000249	0.00293	CbGeAlD
Fluoxetine—CYP2D6—nervous system—schizophrenia	0.000245	0.00289	CbGeAlD
Fluoxetine—CYP3A4—central nervous system—schizophrenia	0.00024	0.00282	CbGeAlD
Fluoxetine—CYP2D6—central nervous system—schizophrenia	0.000236	0.00278	CbGeAlD
Fluoxetine—Duloxetine—CYP2D6—schizophrenia	0.000235	0.0352	CrCbGaD
Fluoxetine—Atomoxetine—SLC6A3—schizophrenia	0.000234	0.0351	CrCbGaD
Fluoxetine—CYP2D6—cerebellum—schizophrenia	0.00023	0.00272	CbGeAlD
Fluoxetine—ABCB1—blood—schizophrenia	0.000217	0.00256	CbGeAlD
Fluoxetine—ABCB1—midbrain—schizophrenia	0.000214	0.00253	CbGeAlD
Fluoxetine—Atomoxetine—HTR2C—schizophrenia	0.000212	0.0317	CrCbGaD
Fluoxetine—HTR2A—brain—schizophrenia	0.000205	0.00242	CbGeAlD
Fluoxetine—ABCB1—endocrine gland—schizophrenia	0.000188	0.00222	CbGeAlD
Fluoxetine—CYP2D6—brain—schizophrenia	0.000187	0.00221	CbGeAlD
Fluoxetine—ABCB1—nervous system—schizophrenia	0.000176	0.00208	CbGeAlD
Fluoxetine—Atomoxetine—SLC6A4—schizophrenia	0.000175	0.0263	CrCbGaD
Fluoxetine—ABCB1—central nervous system—schizophrenia	0.00017	0.002	CbGeAlD
Fluoxetine—ABCB1—cerebellum—schizophrenia	0.000166	0.00195	CbGeAlD
Fluoxetine—Atomoxetine—HTR2A—schizophrenia	0.000135	0.0202	CrCbGaD
Fluoxetine—ABCB1—brain—schizophrenia	0.000135	0.00159	CbGeAlD
Fluoxetine—Atomoxetine—CYP2D6—schizophrenia	0.000123	0.0185	CrCbGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—APOA1—schizophrenia	1.07e-05	9.8e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CYP2D6—schizophrenia	1.06e-05	9.67e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—SNAP25—schizophrenia	1.06e-05	9.67e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NPS—schizophrenia	1.06e-05	9.67e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NDUFV2—schizophrenia	1.05e-05	9.57e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—DRD2—schizophrenia	1.05e-05	9.56e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR7—schizophrenia	1.05e-05	9.56e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD1—schizophrenia	1.04e-05	9.48e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HTR2C—schizophrenia	1.04e-05	9.48e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GAPDH—schizophrenia	1.04e-05	9.46e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—SNAP25—schizophrenia	1.03e-05	9.45e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CYP2D6—schizophrenia	1.03e-05	9.45e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—TPH1—schizophrenia	1.03e-05	9.4e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GCLM—schizophrenia	1.03e-05	9.4e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CLOCK—schizophrenia	1.03e-05	9.38e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.02e-05	9.36e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CACNA1C—schizophrenia	1.02e-05	9.31e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.01e-05	9.25e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GAPDH—schizophrenia	1.01e-05	9.24e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NTRK2—schizophrenia	1.01e-05	9.22e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD3—schizophrenia	1.01e-05	9.18e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CLOCK—schizophrenia	1e-05	9.15e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—TPH2—schizophrenia	1e-05	9.14e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CACNB2—schizophrenia	1e-05	9.14e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PIK3C2A—schizophrenia	9.94e-06	9.07e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PRL—schizophrenia	9.89e-06	9.03e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIP4K2A—schizophrenia	9.85e-06	9e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—DPYD—schizophrenia	9.84e-06	8.99e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—TPH2—schizophrenia	9.77e-06	8.92e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CACNB2—schizophrenia	9.77e-06	8.92e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	9.77e-06	8.92e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD4—schizophrenia	9.76e-06	8.91e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	9.7e-06	8.86e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PRKD1—schizophrenia	9.67e-06	8.83e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—DPYD—schizophrenia	9.61e-06	8.78e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CYP1A2—schizophrenia	9.57e-06	8.74e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GAPDH—schizophrenia	9.53e-06	8.7e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GAPDH—schizophrenia	9.45e-06	8.63e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CLOCK—schizophrenia	9.44e-06	8.63e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—TH—schizophrenia	9.44e-06	8.62e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	9.4e-06	8.58e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CLOCK—schizophrenia	9.36e-06	8.55e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CYP1A2—schizophrenia	9.36e-06	8.55e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	9.34e-06	8.53e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CNR1—schizophrenia	9.32e-06	8.51e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	9.23e-06	8.43e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—TH—schizophrenia	9.22e-06	8.42e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—S100B—schizophrenia	9.21e-06	8.41e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CACNB2—schizophrenia	9.2e-06	8.41e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—TPH2—schizophrenia	9.2e-06	8.41e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CACNA1C—schizophrenia	9.15e-06	8.36e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—TPH2—schizophrenia	9.12e-06	8.33e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CACNB2—schizophrenia	9.12e-06	8.33e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HTR7—schizophrenia	9.09e-06	8.3e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD2—schizophrenia	9.09e-06	8.3e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—DPYD—schizophrenia	9.05e-06	8.27e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—DPYD—schizophrenia	8.98e-06	8.2e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CACNA1C—schizophrenia	8.93e-06	8.16e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PIK3C2A—schizophrenia	8.92e-06	8.15e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—SNAP25—schizophrenia	8.91e-06	8.14e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CYP2D6—schizophrenia	8.91e-06	8.14e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP26B1—schizophrenia	8.91e-06	8.14e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ERBB4—schizophrenia	8.81e-06	8.05e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PIK3C2A—schizophrenia	8.71e-06	7.95e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PRL—schizophrenia	8.58e-06	7.84e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CACNA1C—schizophrenia	8.42e-06	7.69e-05	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—AKT1—schizophrenia	8.37e-06	7.65e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CACNA1C—schizophrenia	8.35e-06	7.62e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PLA2G4A—schizophrenia	8.28e-06	7.57e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	8.25e-06	7.53e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PIK3C2A—schizophrenia	8.2e-06	7.49e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PIK3C2A—schizophrenia	8.13e-06	7.43e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NRG1—schizophrenia	8.13e-06	7.43e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GAPDH—schizophrenia	8.07e-06	7.37e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CYP1A2—schizophrenia	8.06e-06	7.36e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MEF2C—schizophrenia	8.06e-06	7.36e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—COMT—schizophrenia	8.02e-06	7.33e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CLOCK—schizophrenia	8e-06	7.31e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—S100B—schizophrenia	8e-06	7.31e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—SNAP25—schizophrenia	8e-06	7.31e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CYP2D6—schizophrenia	8e-06	7.31e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GSTP1—schizophrenia	7.99e-06	7.29e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	7.98e-06	7.29e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MAOA—schizophrenia	7.97e-06	7.28e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—TH—schizophrenia	7.94e-06	7.25e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—TPH1—schizophrenia	7.94e-06	7.25e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GCLM—schizophrenia	7.94e-06	7.25e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	7.89e-06	7.21e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—COMT—schizophrenia	7.84e-06	7.16e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CYP2D6—schizophrenia	7.81e-06	7.13e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—SNAP25—schizophrenia	7.81e-06	7.13e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GSTP1—schizophrenia	7.81e-06	7.13e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—TPH2—schizophrenia	7.8e-06	7.12e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CACNB2—schizophrenia	7.8e-06	7.12e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—YWHAZ—schizophrenia	7.79e-06	7.11e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MAOA—schizophrenia	7.79e-06	7.11e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—DPYD—schizophrenia	7.67e-06	7.01e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ERBB4—schizophrenia	7.65e-06	6.99e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ERBB3—schizophrenia	7.62e-06	6.96e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ABCB1—schizophrenia	7.56e-06	6.9e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PRKD1—schizophrenia	7.47e-06	6.82e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ABCB1—schizophrenia	7.39e-06	6.75e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—SNAP25—schizophrenia	7.36e-06	6.72e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PLA2G4A—schizophrenia	7.34e-06	6.7e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GSTM1—schizophrenia	7.34e-06	6.7e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR2A—schizophrenia	7.33e-06	6.7e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CYP2D6—schizophrenia	7.29e-06	6.66e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—SNAP25—schizophrenia	7.29e-06	6.66e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CYP1A2—schizophrenia	7.23e-06	6.61e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PLA2G4A—schizophrenia	7.19e-06	6.57e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PLA2G4A—schizophrenia	7.17e-06	6.55e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GSTM1—schizophrenia	7.17e-06	6.55e-05	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—EP300—schizophrenia	7.14e-06	6.52e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CACNA1C—schizophrenia	7.13e-06	6.51e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—TH—schizophrenia	7.13e-06	6.51e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CYP1A2—schizophrenia	7.06e-06	6.45e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NRG1—schizophrenia	7.06e-06	6.45e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MEF2C—schizophrenia	7e-06	6.39e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—TH—schizophrenia	6.96e-06	6.36e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PIK3C2A—schizophrenia	6.95e-06	6.35e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—APOE—schizophrenia	6.82e-06	6.23e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—YWHAZ—schizophrenia	6.76e-06	6.18e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—COMT—schizophrenia	6.75e-06	6.17e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—APOA1—schizophrenia	6.74e-06	6.15e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GSTP1—schizophrenia	6.72e-06	6.14e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MAOA—schizophrenia	6.71e-06	6.12e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CYP1A2—schizophrenia	6.65e-06	6.08e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ERBB3—schizophrenia	6.61e-06	6.04e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CYP1A2—schizophrenia	6.6e-06	6.03e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—TH—schizophrenia	6.56e-06	5.99e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ESR1—schizophrenia	6.51e-06	5.94e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.5e-06	5.94e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—TH—schizophrenia	6.5e-06	5.94e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MTHFR—schizophrenia	6.49e-06	5.92e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ABCB1—schizophrenia	6.36e-06	5.81e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MTHFR—schizophrenia	6.34e-06	5.79e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—SNAP25—schizophrenia	6.23e-06	5.69e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CYP2D6—schizophrenia	6.23e-06	5.69e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GAPDH—schizophrenia	6.23e-06	5.69e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PLA2G4A—schizophrenia	6.18e-06	5.64e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GSTM1—schizophrenia	6.18e-06	5.64e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CLOCK—schizophrenia	6.17e-06	5.64e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—COMT—schizophrenia	6.06e-06	5.54e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—APOE—schizophrenia	6.04e-06	5.51e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GSTP1—schizophrenia	6.03e-06	5.51e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MAOA—schizophrenia	6.02e-06	5.5e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—TPH2—schizophrenia	6.02e-06	5.5e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CACNB2—schizophrenia	6.02e-06	5.5e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—APOA1—schizophrenia	5.97e-06	5.45e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—DPYD—schizophrenia	5.92e-06	5.41e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—APOE—schizophrenia	5.92e-06	5.41e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—COMT—schizophrenia	5.92e-06	5.4e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—GSK3B—schizophrenia	5.9e-06	5.39e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—APOE—schizophrenia	5.9e-06	5.39e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GSTP1—schizophrenia	5.89e-06	5.38e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MAOA—schizophrenia	5.88e-06	5.37e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—APOA1—schizophrenia	5.85e-06	5.34e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—schizophrenia	5.84e-06	5.33e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—APOA1—schizophrenia	5.83e-06	5.33e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ABCB1—schizophrenia	5.71e-06	5.22e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ESR1—schizophrenia	5.65e-06	5.16e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—COMT—schizophrenia	5.58e-06	5.09e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—TH—schizophrenia	5.56e-06	5.07e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GSTP1—schizophrenia	5.55e-06	5.07e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PLA2G4A—schizophrenia	5.55e-06	5.06e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GSTM1—schizophrenia	5.55e-06	5.06e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MAOA—schizophrenia	5.54e-06	5.06e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—COMT—schizophrenia	5.53e-06	5.05e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CACNA1C—schizophrenia	5.5e-06	5.03e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GSTP1—schizophrenia	5.5e-06	5.03e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MAOA—schizophrenia	5.49e-06	5.01e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MTHFR—schizophrenia	5.46e-06	4.99e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PLA2G4A—schizophrenia	5.41e-06	4.94e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GSTM1—schizophrenia	5.41e-06	4.94e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIK3C2A—schizophrenia	5.36e-06	4.9e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	5.32e-06	4.86e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ABCB1—schizophrenia	5.25e-06	4.8e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ABCB1—schizophrenia	5.21e-06	4.76e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GSK3B—schizophrenia	5.13e-06	4.68e-05	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TP53—schizophrenia	5.11e-06	4.67e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PLA2G4A—schizophrenia	5.1e-06	4.66e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GSTM1—schizophrenia	5.1e-06	4.66e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—APOE—schizophrenia	5.08e-06	4.64e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PLA2G4A—schizophrenia	5.06e-06	4.62e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GSTM1—schizophrenia	5.06e-06	4.62e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—APOA1—schizophrenia	5.02e-06	4.59e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MTHFR—schizophrenia	4.9e-06	4.48e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP2D6—schizophrenia	4.81e-06	4.39e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SNAP25—schizophrenia	4.81e-06	4.39e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MTHFR—schizophrenia	4.78e-06	4.37e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—COMT—schizophrenia	4.72e-06	4.31e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GSTP1—schizophrenia	4.7e-06	4.29e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MAOA—schizophrenia	4.69e-06	4.28e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOE—schizophrenia	4.56e-06	4.17e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.55e-06	4.15e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOA1—schizophrenia	4.51e-06	4.12e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MTHFR—schizophrenia	4.51e-06	4.12e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MTHFR—schizophrenia	4.47e-06	4.08e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOE—schizophrenia	4.45e-06	4.07e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ABCB1—schizophrenia	4.45e-06	4.06e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOA1—schizophrenia	4.4e-06	4.02e-05	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—AKT1—schizophrenia	4.38e-06	4e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP1A2—schizophrenia	4.35e-06	3.97e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PLA2G4A—schizophrenia	4.32e-06	3.95e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GSTM1—schizophrenia	4.32e-06	3.95e-05	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—AKT1—schizophrenia	4.32e-06	3.94e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—TH—schizophrenia	4.29e-06	3.92e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOE—schizophrenia	4.2e-06	3.83e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOE—schizophrenia	4.16e-06	3.8e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOA1—schizophrenia	4.15e-06	3.79e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOA1—schizophrenia	4.11e-06	3.76e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—AKT1—schizophrenia	3.97e-06	3.63e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—EP300—schizophrenia	3.88e-06	3.55e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MTHFR—schizophrenia	3.82e-06	3.49e-05	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—AKT1—schizophrenia	3.8e-06	3.47e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—COMT—schizophrenia	3.65e-06	3.33e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GSTP1—schizophrenia	3.63e-06	3.31e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MAOA—schizophrenia	3.62e-06	3.31e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOE—schizophrenia	3.55e-06	3.25e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOA1—schizophrenia	3.51e-06	3.21e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—AKT1—schizophrenia	3.45e-06	3.15e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—EP300—schizophrenia	3.44e-06	3.14e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ABCB1—schizophrenia	3.43e-06	3.14e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—EP300—schizophrenia	3.37e-06	3.08e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—EP300—schizophrenia	3.36e-06	3.07e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PLA2G4A—schizophrenia	3.33e-06	3.05e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GSTM1—schizophrenia	3.33e-06	3.05e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MTHFR—schizophrenia	2.95e-06	2.69e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—EP300—schizophrenia	2.9e-06	2.65e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TP53—schizophrenia	2.78e-06	2.54e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOE—schizophrenia	2.74e-06	2.51e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOA1—schizophrenia	2.71e-06	2.48e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—EP300—schizophrenia	2.6e-06	2.37e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—EP300—schizophrenia	2.54e-06	2.32e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TP53—schizophrenia	2.41e-06	2.2e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—EP300—schizophrenia	2.39e-06	2.18e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—EP300—schizophrenia	2.37e-06	2.17e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—AKT1—schizophrenia	2.35e-06	2.14e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—AKT1—schizophrenia	2.08e-06	1.9e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—AKT1—schizophrenia	2.04e-06	1.86e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—AKT1—schizophrenia	2.03e-06	1.86e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—EP300—schizophrenia	2.03e-06	1.85e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—AKT1—schizophrenia	1.75e-06	1.6e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—AKT1—schizophrenia	1.57e-06	1.44e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—EP300—schizophrenia	1.56e-06	1.43e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—AKT1—schizophrenia	1.53e-06	1.4e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—AKT1—schizophrenia	1.45e-06	1.32e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—AKT1—schizophrenia	1.43e-06	1.31e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—AKT1—schizophrenia	1.22e-06	1.12e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AKT1—schizophrenia	9.45e-07	8.63e-06	CbGpPWpGaD
